FDA Approved: VALSTAR — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VALSTAR (valrubicin) submitted by Endo USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Carcinoma in Situ of the Bladder

Drugs mentioned

• VALSTAR (valrubicin)

Snippet

SUPPL AP for VALSTAR (VALRUBICIN)